期刊文献+

CD40调节胰腺癌细胞生物学行为的研究 被引量:2

Effects of CD40 pathway on the biological behavior of pancreatic cancer cells
下载PDF
导出
摘要 目的:研究CD40L对胰腺癌细胞生物学特性、干性的影响。方法:CCK-8活细胞计数法分析CD40可溶性配体(s CD40L)不同浓度(0、1、2、4μg/m L)在不同时间对人胰腺癌细胞系panc02生长增殖的影响,Annexin V/PI双染法检测凋亡;细胞划痕实验检测迁移的改变。Q-PCR检测4μg/m L s CD40L处理panc02 48 h后c-Myc、OCT-4、Sox-2水平的改变。建立Balb/c裸鼠胰腺癌荷瘤模型,随机分为2组,对照组(生理盐水)和s CD40L(10 mg/kg)组,分别腹腔注射s CD40L 10mg/kg以及等体积生理盐水,每天注射3次,游标卡尺测量0、7、14、21、28 d时肿瘤体积。结果:与对照组比较,浓度为1、2、4μg/m L的s CD40L处理panc02 96 h时可显著抑制panc02的增殖(P<0.01),并促进panc02的凋亡(P<0.01),并呈剂量依赖性地抑制panc02的迁移能力(P<0.01);s CD40L 4μg/m L组可明显抑制panc02细胞的cMyc、OCT-4、Sox-2的表达(P<0.01)。在裸鼠荷瘤实验中,与对照组比较,s CD40L处理28 d明显抑制肿瘤体积(P<0.01,252±13 vs.189±9)。结论:CD40通路的活化能够抑制胰腺癌细胞增殖迁移、促进凋亡,同时抑制胰腺癌细胞系体内的增殖能力,而这一效应可能与CD40L抑制胰腺癌细胞系干性相关。 AIM:To study the effect of CD40 L on the biological characteristics and stenness of pancreatic cancer cells.METHODS:The effect of different concentrations of s CD40 L(0,1,2,4 μg/m L) on the proliferation of human pancreatic cancer cell line panc02 was analyzed by CCK-8 live cell counting assay.Apoptosis was detected by Annexin V/PI double staining;migrational ability was detected by Cell Scratch Assays.Q-PCR was used to detect the levels of c-Myc,OCT-4 and Sox-2 after panc02 treatment for 4 h/m L s CD40 L.A Balb/c nude mouse model of pancreatic cancer was established and randomly divided into two groups:control group(normal saline) and s CD40 L(10 mg/kg)group.They were injected intraperitoneally with s CD40 L 10 mg/kg and an equal volume of saline for three times a day.Tumor volume was measured using vernier calipers at 0,7 th,14 th,21 st,and28 th day.RESULTS:Compared with the control group,the growth and migration of panc02 decreased significantly after s CD40 L treatment(1,2,4 μg/m L for 96 h),and apoptosis was promoted in a dose-dependent manner(P〈0.01).s CD40 L(4μg/m L) significantly inhibited the expression of cMyc,OCT-4,Sox-2 of panc02(P〈0.01).In the nude mice tumor-bearing experiment,compared with the control group,s CD40 L significantly inhibited the tumor volume at 28 th day(P〈0.01,252 ± 13 vs.189 ± 9).CONCLUSION:Activation of CD40 pathway inhibits proliferation,migration and apoptosis of pancreatic cancer cells as well as the proliferation of pancreatic cancer cell lines in vivo.This effect may be related to the change of stemness in pancreatic cancer cell lines.
作者 张桂枫 蔡加琴 崔同建 刘振华 许志贤 ZHANG Guifeng;CAI Jiaqin;CUI Tongjian;LIU Zhenhua;XU Zhixian(Provincial Clinical College of Fujian Medical University,Fujian Provincial Hospital,Fuzhou 350001,Fujian,China;Department of Pharmacy,Fujian Provincial Hospital,Fuzhou 350001,Fujian,China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2018年第7期755-760,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 福建省卫生计生青年科研课题(2013037) 福建医科大学启航基金项目计划(2016QH106)
关键词 胰腺癌 体内外增殖 CD40/CD40L 干性 pancreatic cancer proliferation in vivo and in vitro CD40/CD40L sternness
  • 相关文献

参考文献1

二级参考文献33

  • 1Koho H,Paulie S,Ben-Aissa H et al.Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder(Ⅰ).Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence[J].Cancer Immunol Immunother,1984; 17(3):165-172.
  • 2Imadome K,Shimizu N,Arai A et al.Coexpression of CD40 and CD40 ligand in Epstein-Barr Virus-infected T and NK cells and their role in cell survival[J].J Infect Dis,2005; 192(8):1340-1348.
  • 3Lebre M C,Burwell T,Vieira P L et al.Differential expression of inflammatory chemokines by Th1-and Th2-cell promoting dendritic cells:a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation[J].Immunol Cell Biol,2005; 83(5):525-535.
  • 4Loskog A,Dzojic H,Vikman S et al.Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment[J].J Immunol,2004; 172(11):7200-7205.
  • 5Bhushan A,Covey L R.CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes[J].Immunol Res,2001; 24(3):311-324.
  • 6Vowinkel T,Wood K C,Stokes K Y et al.Differential expression and regulation of murine CD40 in regional vascular beds[J].Am J Physiol Heart Circ Physiol,2005;290(2):H631-H639.
  • 7Voorzanger-Rousselot N,Blay J Y.Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells:an autocrine anti-apoptotic role[J].Leuk Lymphoma,2004; 45(6):1239-1245.
  • 8Ghamande S,Hylander B L,Oflazoglu E et al.Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin[J].Cancer Res,2001; 61(20):7556-7562.
  • 9Moore C R,Bishop G A.Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes[J].J Immunol,2005; 175(6):3780-3789.
  • 10Davies C C,Mak T W,Young L S et al.TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells[J].Mol Cell Biol,2005; 25(22):9806-9819.

共引文献2

同被引文献20

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部